Lilly Plant Making Covid Drug Flagged Again by Inspectors

Bookmark
(Bloomberg) -- U.S. drug-safety inspectors have found continuing quality-control problems problems at a New Jersey plant Eli Lilly & Co. is using to help produce its Covid-19 antibody therapy, posi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.